| 46.35 BATS BZX Real-Time Price As of 9:47am ET |  +0.175 / +0.38%Today’s Change | 40.00 Today|||52-Week Range 47.11 | +6.76% Year-to-Date |
| Here's Why Dermira Stock Is Rocketing Higher Today Oct 18 / MotleyFool.com - Paid Partner Content | Should Investors Buy or Sell Sangamo Therapeutics Right Now? Oct 08 / MotleyFool.com - Paid Partner Content |
| Big Pharma Has Mad Love For These 2 Biotechs Oct 11 / MotleyFool.com - Paid Partner Content | Here’s Why Emergent BioSolutions Stock Climbed 19.4% in September Oct 07 / MotleyFool.com - Paid Partner Content |
| Why Amicus Therapeutics Stock Folded in September Oct 08 / MotleyFool.com - Paid Partner Content |
| Previous close | 46.17 |
| Today’s open | 46.38 |
| Day’s range | 46.30 - 46.41 |
| Volume | 18,001 |
| Average volume (3 months) | 1,497,553 |
| Market cap | $115.0B |
| Earnings growth (last year) | +19.94% |
| Earnings growth (this year) | +3.64% |
| Earnings growth (next 5 years) | +5.00% |
| Revenue growth (last year) | +2.83% |
| P/E ratio | 29.0 |
| Price/Sales | 2.68 |
| Price/Book | 1.71 |
| Today’s change | Today’s % change | |
|---|---|---|
| AZNAstraZeneca | -0.10 | -0.23% |
| ABBVAbbVie | -0.37 | -0.48% |
| GSKGlaxoSmithKline | +0.03 | +0.07% |
| LLYEli Lilly and Co | -0.20 | -0.18% |
| Next reporting date | October 30, 2019 |
| EPS forecast (this quarter) | $0.94 |
| Annual revenue (last year) | $40.7B |
| Annual profit (last year) | $5.1B |
| Net profit margin | 12.53% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Paris, Ile-de-france |
